Abstract: This invention introduces the use of Lactobacillus acidophilus LA05 in preparing products designed to reduce blood uric acid levels. The strain, stored under CGMCC No. 23546, demonstrates survival under low pH and bile salt conditions and has a significant capability to lower blood uric acid. The applications of this probiotic extend to various products, including...